doi: 10.1111/cei.12167 66 Reyes-PrezIVSnchez-HernndezPEMuoz-ValleJFMartnez-BonillaGEGarca-IglesiasTGonzlez-DazVet al
P-133 Clinical responses in pancreaticobiliary cancer patients who received bintrafusp alfa (BA) or BA plus CXCR1/2 inhibitor (SX-682) plus CEA/MUC1-targted vaccine (CV301)
Many patients incorporate it as part of a broader wellness plan to complement nutrition, lifestyle, and other targeted therapies
Address gut health: If microbial markers are elevated, targeted gut support may be an important first step in improving cognitive and mood symptoms
Biofilm and Chronic Nonhealing Wound Infections
DHondt M, Bracke N, Taevernier L, Gevaert B, Verbeke F, Wynendaele E, De Spiegeleer B